Harlan S. Robins, Chief Scientific Officer at Adaptive Biotechnologies Corp (ADPT), sold 136,824 shares at $7.35 ($1.0M) on 2025-05-01, disclosed to the SEC on 2025-05-05.
Scheduled sale ($1.0M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.35 | 68,412 | $503K | 50.0% |
| 2 | $7.35 | 68,412 | $503K | 50.0% |
| Total | $7.35 avg | 136,824 | $1.0M | 100% |
| Filing → |
| ADPT | SELL | 2026-06-17 | $1.8M | — | Filing → |
| ADPT | SELL | 2026-04-10 | $149K | — | Filing → |
| ADPT | SELL | 2026-03-13 | $6.2M | — | Filing → |